Publications by authors named "L A Yarbro"
Article Synopsis
- Florida's Big Bend harbors the second-largest seagrass meadow in the continental U.S., crucial for carbon cycling and ecosystem health.
- Over 21 years of mapping and 13 years of monitoring show significant seagrass decline, with a 15% reduction in area to 85,170 ha by 2022, particularly in the southern regions where losses were as high as 90-100%.
- The Northern Big Bend retained most of the seagrass area (85%), showing only 8.4% loss; however, overall species frequency and cover have decreased, raising concerns about long-term ecological impacts and the potential for recovery if conditions improve.
Introduction: The integration of clinical oncology pharmacists into multidisciplinary healthcare teams is not well-described in the community practice setting. This study aims to analyze the clinical and financial impact of a remote-based clinical oncology pharmacist in four community oncology practices within The US Oncology Network.
Methods: Oncology-trained clinical pharmacists electronically reviewed chemotherapy orders for clinical optimization and financial stewardship within four community oncology practices.
We examined the response of demographic, morphological, and chemical parameters of turtle grass (Thalassia testudinum), to much-higher-than-normal rainfall associated with an El Niño event in the winter of 1997-1998. Up to 20 inches of added rain fell between December 1997 and March 1998. triggering widespread and persistent phytoplankton blooms along the west coast of Florida.
View Article and Find Full Text PDFThe excretion rates of the C19-mineralcorticoids, 16beta-hydroxy-DHEA and 16-oxo-androstenediol, were measured in subjects with low-renin essential hypertension and toxemia of pregnancy. C19-mineralocorticoid excretion in low-renin essential hypertension ranged from 70-790 microgram per day. No significant difference in 16beta-hydroxy-DHEA and 16-oxo-androstenediol excretion was found between these subjects and normal controls.
View Article and Find Full Text PDFArticle Synopsis
- The study investigates the causes of high blood pressure in two conditions: primary aldosteronism and low-renin essential hypertension, linking both to mineralocorticoid excess.
- The research shows that while primary aldosteronism clearly involves increased aldosterone leading to high blood pressure, low-renin essential hypertension may be related to an unknown mineralocorticoid despite normal aldosterone levels.
- During treatment with adrenal inhibitors, both conditions showed blood pressure reduction; however, in low-renin essential hypertension, blood pressure did not significantly change despite a decrease in aldosterone, indicating a likely role of other unidentified mineralocorticoids in this condition.